Keles

Keles is a healthcare-dedicated private equity firm investing across early-stage, venture, and growth equity opportunities. The firm targets healthcare services, digital health, and medtech companies primarily within European markets. Its multi-stage approach allows it to support companies from early development through commercial scaling.

Keles operates as a single-sector specialist rather than a generalist fund, concentrating entirely on healthcare. This sector focus allows the firm to build deep operational expertise, specialized networks, and repeatable value-creation playbooks specific to healthcare companies. Generalist firms typically lack this level of domain concentration.

The firm targets early-stage, venture, and growth-stage investments across the healthcare sector. This multi-stage mandate means Keles can participate in a company's first institutional round and continue supporting it through later growth equity rounds, rather than being limited to a single stage.

Keles is headquartered in Paris, France, and focuses its investment activity on European healthcare markets. The firm's Paris location provides access to one of Europe's largest and most innovative healthcare ecosystems, including strong university-hospital networks and research institutions.

Keles does not publicly disclose its assets under management or a detailed list of portfolio companies. The firm maintains a low public profile, consistent with many specialist private equity managers that prefer to communicate performance and holdings directly to limited partners rather than through public channels.